Forge Therapeutics' Series A Round

Forge Therapeutics raised a round of funding on April 25, 2017.

Forge Therapeutics is a biotechnology company developing medicines by combining bio-inorganic with medicinal chemistry to target metalloproteins.…

Articles about Forge Therapeutics' Series A Round: